TL;DR: The Centers for Medicare & Medicaid Services modified NCD 108 governing 24-hour ambulatory esophageal pH monitoring, effective March 7, 2026. Here's what changes for billing teams.
CMS esophageal pH monitoring coverage policy under NCD 108 Medicare is a narrow benefit — and it just got a formal update. The policy covers pH monitoring for suspected gastric reflux, but only under two specific clinical scenarios. No CPT or HCPCS codes are listed in the policy document itself, which creates a real documentation burden for billing teams. If your practice bills for esophageal pH studies, audit your medical necessity documentation before March 7, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | 24-Hour Ambulatory Esophageal pH Monitoring |
| Policy Code | NCD 108 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Gastroenterology, General Surgery, Internal Medicine, ENT |
| Key Action | Confirm medical necessity documentation meets both coverage criteria before billing for pH monitoring studies on Medicare patients |
CMS 24-Hour Ambulatory Esophageal pH Monitoring Coverage Criteria and Medical Necessity Requirements 2026
NCD 108 is the National Coverage Determination governing Medicare coverage of 24-hour ambulatory esophageal pH monitoring. The procedure involves placing an indwelling electrode into the lower esophagus. It measures gastric reflux and abnormal esophageal acid exposure over a 24-hour period.
The coverage policy is narrow. Medicare does not cover pH monitoring as a routine diagnostic step for every patient with reflux symptoms. The Centers for Medicare & Medicaid Services limits coverage to two specific patient presentations.
First: The patient is suspected of having gastric reflux and presents diagnostic problems associated with atypical symptoms. Think chest pain of unclear origin, chronic cough, hoarseness, or dental erosion — cases where reflux is on the differential but the clinical picture doesn't fit the textbook.
Second: The patient's symptoms are suggestive of reflux, but conventional tests have not confirmed the presence of reflux. "Conventional tests" means upper endoscopy and barium swallow studies — the standard workup a physician would order before escalating to pH monitoring.
Both criteria hinge on medical necessity documentation. If your physician's notes don't clearly establish which scenario applies — atypical symptoms or failed conventional testing — expect a claim denial. That's not a risk you manage after the fact. It's a documentation standard you build into your intake process now.
This coverage policy does not mention prior authorization requirements, which is consistent with most NCD-level policies. Coverage is based on meeting the published criteria at the time of service, not on pre-approval. That said, if you bill through a Medicare Advantage plan, prior authorization rules may apply at the plan level. Always check the specific Medicare Advantage payer policy before scheduling.
The reimbursement question for esophageal pH monitoring billing is complicated by one key fact: NCD 108 does not list specific CPT or HCPCS codes. That means your billing team must confirm the correct procedure codes internally — typically through the relevant Medicare Administrative Contractor fee schedule — and then map medical necessity documentation to those codes with precision.
CMS Esophageal pH Monitoring Exclusions and Non-Covered Indications
NCD 108 draws a clear line. Coverage exists only when the patient meets one of the two criteria above. Every other clinical scenario is implicitly non-covered.
If a patient has classic GERD symptoms and a positive endoscopy already confirms reflux, pH monitoring is not covered. CMS considers conventional testing sufficient in that situation. Ordering pH monitoring on top of a confirmed diagnosis will not survive a medical necessity review.
Routine or screening pH monitoring — ordered without a specific diagnostic problem — is also not covered. The clinical record needs to show that the physician was trying to resolve a genuine diagnostic question, not checking a box.
The policy does not designate pH monitoring as experimental or investigational. For the right patient, it is a covered diagnostic service. But the coverage criteria are tight, and documentation gaps are the most common reason these claims fail.
Coverage Indications at a Glance
| Indication | Coverage Status | Relevant Codes | Notes |
|---|---|---|---|
| Suspected gastric reflux with atypical symptoms (e.g., chest pain, chronic cough, hoarseness) | Covered | Not specified in NCD 108 | Documentation must establish atypical symptom presentation |
| Symptoms suggestive of reflux where conventional tests have not confirmed reflux | Covered | Not specified in NCD 108 | Must document prior negative or inconclusive endoscopy or barium study |
| Suspected reflux with already-confirmed diagnosis via conventional testing | Not Covered | — | Conventional confirmation removes medical necessity for pH monitoring |
| Routine or screening pH monitoring without a specific diagnostic question | Not Covered | — | No diagnostic problem documented = claim denial risk |
| Medicare Advantage patients in either covered scenario | Varies by plan | — | Check plan-level prior authorization requirements before scheduling |
CMS Esophageal pH Monitoring Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 gives you a fixed target. Here's what your billing team and clinical staff need to do before then.
| # | Action Item |
|---|---|
| 1 | Audit your current documentation templates for pH monitoring orders. Your physicians need to explicitly document either atypical symptoms or the results of prior conventional testing that failed to confirm reflux. A generic "rule out GERD" order will not meet medical necessity criteria under NCD 108. Update order templates now so the right language is captured at the point of care. |
| 2 | Identify the correct CPT codes for esophageal pH monitoring billing at your practice. NCD 108 does not list codes. Contact your Medicare Administrative Contractor or check the current fee schedule to confirm which procedure codes apply to your pH monitoring studies. Build those codes into your charge capture system with NCD 108 as the governing policy. |
| 3 | Train your billing team on the two-criteria rule. Claims reviewers on your team should be able to look at a pH monitoring claim and immediately identify which coverage criterion applies — atypical symptoms or failed conventional testing. If they can't find documentation supporting one of those two scenarios, the claim should not go out the door. |
| 4 | Check Medicare Advantage plan policies for any pH monitoring prior authorization requirements. NCD 108 applies to traditional Medicare. Your Medicare Advantage payers may have their own coverage policy, different medical necessity criteria, or prior authorization requirements that override NCD 108. Pull those policies for every MA plan in your payer mix and compare them to the NCD criteria. |
| 5 | Set up a claim denial tracking filter for pH monitoring. If you're not already tracking denial reasons by procedure, start now. A spike in medical necessity denials for pH monitoring after March 7, 2026 is a signal that your documentation process isn't capturing the right criteria. Catch that pattern early, before it becomes a write-off problem. |
| 6 | Loop in your compliance officer if your practice does high volume of pH monitoring. The narrow coverage criteria in NCD 108 create real exposure if your documentation practices are inconsistent. If you're not sure how this applies to your patient mix or physician documentation habits, get your compliance officer involved before the effective date — not after a post-payment audit. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for 24-Hour Ambulatory Esophageal pH Monitoring Under NCD 108
A Note on Code Availability
NCD 108 does not list specific CPT, HCPCS, or ICD-10 codes in the policy document. This is not unusual for older National Coverage Determinations, but it does put the code identification burden on your billing team.
Your primary resource for code mapping is your regional Medicare Administrative Contractor. The MAC for your jurisdiction publishes local coverage determinations and billing guidelines that often fill in the code-level detail that NCDs leave out. Check for an LCD that cross-references NCD 108 in your region — some MACs have published companion documents that specify acceptable procedure codes for esophageal pH studies.
For reference, esophageal pH monitoring procedures are typically reported under CPT codes in the gastrointestinal function testing range, but confirm the exact codes with your MAC before updating charge capture. Using an unconfirmed code and getting it wrong creates more denial risk than taking the extra step to verify.
ICD-10-CM Diagnosis Codes
NCD 108 does not list specific ICD-10-CM codes. Your diagnosis coding for covered cases should reflect the clinical scenario — atypical symptoms or inconclusive conventional testing. Work with your coding team to identify the appropriate ICD-10-CM codes for the specific presentation documented in the medical record. Map those codes to the NCD 108 coverage criteria in your internal billing guidelines.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.